← Back
Data updated: Mar 10, 2026
IVAX RES
Infectious Disease
IVAX RES is a specialty pharmaceutical company focused on Infectious Disease.
1981
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 1981-09-24
- Latest
- 2007-12-07
- Applications
- 1